UCB PHARMA SA
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Public, Subsidiary
- Established
- 1928-01-01
- Employees
- 9K
- Market Cap
- $34.9B
Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine
- First Posted Date
- 2008-01-15
- Last Posted Date
- 2014-10-02
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 124
- Registration Number
- NCT00593606
Dosing Flexibility Study in Patients With Rheumatoid Arthritis
- First Posted Date
- 2007-12-27
- Last Posted Date
- 2018-08-02
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 333
- Registration Number
- NCT00580840
Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)
Not Applicable
Completed
- Conditions
- Memory Disorders
- First Posted Date
- 2007-12-04
- Last Posted Date
- 2013-12-16
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 676
- Registration Number
- NCT00567060
Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease
Phase 3
Completed
- Conditions
- Crohn Disease
- Interventions
- Other: PlaceboBiological: certolizumab pegol (CDP870, CZP)
- First Posted Date
- 2007-11-01
- Last Posted Date
- 2018-08-09
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 439
- Registration Number
- NCT00552058
To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures
- First Posted Date
- 2007-11-01
- Last Posted Date
- 2018-07-17
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 370
- Registration Number
- NCT00552305
Efficacy and Safety of CDP870 Versus Placebo in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis
Phase 3
Completed
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2007-10-24
- Last Posted Date
- 2013-09-04
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 220
- Registration Number
- NCT00548834
Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.
- First Posted Date
- 2007-10-18
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 621
- Registration Number
- NCT00546351
- Locations
- 🇧🇪
004, Roeselare, Belgium
🇧🇪002, Genk, Belgium
🇧🇪005, Merksem, Belgium
Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arthritis
Phase 3
Completed
- Conditions
- Arthritis, Rheumatoid
- First Posted Date
- 2007-10-16
- Last Posted Date
- 2013-09-04
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 247
- Registration Number
- NCT00544154
A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures
Phase 2
Completed
- Conditions
- Absence Seizures
- First Posted Date
- 2007-10-16
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 4
- Registration Number
- NCT00545012
Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects
Phase 3
Completed
- Conditions
- Rhinitis, Allergic, Seasonal
- First Posted Date
- 2007-10-16
- Last Posted Date
- 2013-12-16
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 570
- Registration Number
- NCT00544388
© Copyright 2025. All Rights Reserved by MedPath